We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02323191
Recruitment Status : Completed
First Posted : December 23, 2014
Last Update Posted : August 27, 2020
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche